Abdul Halim Abdul Gafor
Overview
Explore the profile of Abdul Halim Abdul Gafor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heerspink H, Cherney D, Gafor A, Gorriz J, Pergola P, Tang S, et al.
J Am Soc Nephrol
. 2024 May;
PMID: 38795055
No abstract available.
2.
Shafik N, Ibrahim N, Gafor A
Saudi J Kidney Dis Transpl
. 2024 May;
34(6):642-654.
PMID: 38725213
Hemodialysis (HD) and peritoneal dialysis (PD) treatments impact the economic burden and psychological distress faced by end-stage kidney disease (ESKD) patients and their caregivers. This review aimed to discuss the...
3.
Ibrahim N, Chu S, Siau C, Amit N, Ismail R, Gafor A
BMJ Open
. 2023 Jan;
12(6):e059305.
PMID: 36691236
Introduction: The number of patients in Malaysia requiring dialysis is expected to rise substantially in the future due to the ageing population and increasing prevalence of diabetes mellitus and hypertension....
4.
Sadu Singh B, Khor B, Sahathevan S, Gafor A, Fiaccadori E, Chinna K, et al.
Healthcare (Basel)
. 2022 Oct;
10(10).
PMID: 36292538
The capacity to deliver intradialytic parenteral nutrition (IDPN) for patients on hemodialysis (HD) diagnosed with protein energy wasting (PEW) in low resource settings is unknown. This study aimed to examine...
5.
Loo L, Ong K, Ahmad Nidzwal A, Razali M, Ahmad N, Naim A, et al.
PLoS One
. 2022 Sep;
17(9):e0274038.
PMID: 36149873
The prevalence of chronic kidney disease (CKD) risk factors such as diabetes mellitus, hypertension, and obesity among the young Malaysians are increasing. Understanding the factors associated with CKD knowledge could...
6.
Teong L, Khor B, Ng H, Sahathevan S, Purba K, Narayanan S, et al.
J Pers Med
. 2022 Jun;
12(6).
PMID: 35743746
This study aims to determine the effectiveness of a phosphate mobile app (PMA), MyKidneyDiet-Phosphate Tracker ©2019, on hemodialysis (HD) patients with hyperphosphatemia. A multicenter, open-label, randomized controlled trial design allowed...
7.
Yap K, Baharudin N, Gafor A, Remli R, Lim S, Wan Zaidi W, et al.
J Mov Disord
. 2022 May;
15(3):258-263.
PMID: 35614016
Objective: The basal ganglia (BG) are susceptible to fluctuations in blood urea levels, sometimes resulting in movement disorders. We described patients with end-stage kidney disease (ESKD) presenting with movement disorders...
8.
Shah S, Anuar H, Gafor A, Abdullah N
Sci Rep
. 2022 Apr;
12(1):5694.
PMID: 35383215
Purpose We aimed to determine predictors of chronic kidney disease (CKD) prevention among patients with diabetes. Method A cross-sectional study was conducted on 1000 selected respondents based on socio-demographic, socio-economic,...
9.
Lee F, Islahudin F, Gafor A, Wong H, Bavanandan S, Mohd Saffian S, et al.
Front Pharmacol
. 2022 Apr;
13:848804.
PMID: 35359836
Chronic kidney disease (CKD) patients may be more susceptible to adverse drug reactions (ADRs), given their complex medication regimen and altered physiological state driven by a decline in kidney function....
10.
Teong L, Khor B, Purba K, Gafor A, Goh B, Bee B, et al.
Healthcare (Basel)
. 2022 Mar;
10(3).
PMID: 35327013
Hyperphosphatemia afflicts end-stage chronic kidney disease (CKD) patients, contributing to comorbidities and mortality. Management strategies are dialysis, phosphate binder, and limiting dietary phosphate intake, but treatment barriers are poor patient...